|
|
||||||||
Letters to the Editor |
Departments of1 Neonatology2 Obstetrics and Gynecology and 3 Clinical Biochemistry and 4 Pediatric Cardiology Unit, Hadassah and The Hebrew University Medical Center, Jerusalem, Israel
aAddress correspondence to this author at: Department of Neonatology, Hadassah University Hospital, Mount Scopus, PO Box 24035, Jerusalem, Israel. Fax 972-2-5813068; e-mail baroz@hadassah.org.il or bar-oz@md2.huji.ac.il.
| The first 20% of the full text of this article appears below. |
To the Editor:
The role of the heart as an endocrine organ was established in 1981 by de Bold et al. (1). Usually, in adults, atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) are secreted mainly by the cardiac atria and ventricles, respectively (2). Plasma concentrations of these peptides, particularly that of BNP, have been shown to reflect cardiac dysfunction and volume overload in adults and children (3)(4)(5)(6)(7)(8).
There is evidence that these peptides have possible roles during fetal life in the regulation of organogenesis of the heart and the cardiovascular system, in the regulation of blood pressure and water balance in the developing embryo, and in the transition from fetal to extra-uterine life (9).
The following articles in journals at HighWire Press have cited this article:
![]() |
A El-Khuffash, D Barry, K Walsh, P G Davis, and E J Molloy Biochemical markers may identify preterm infants with a patent ductus arteriosus at high risk of death or severe intraventricular haemorrhage Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2008; 93(6): F407 - F412. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. El-Khuffash and E. J Molloy Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates? Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2007; 92(4): F320 - F324. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |